Device / Technology News

RSS

GE feels pinch of drop in advanced medical imaging

General Electric Co.'s $18 billion health-care business is being forced to navigate a slowdown in medical imaging - one that in some ways has been aggravated by GE itself. GE put its 85,000 U.S. white-collar workers on a high-deductible health plan in an effort to stem the growth of its U.S. health bills, which are now running $2.5 billion a year.

20 Sep 2012

Pacifiers may stunt emotional development of baby boys

Pacifiers may stunt the emotional development of baby boys by robbing them of the opportunity to try on facial expressions during infancy.

20 Sep 2012

Bionic legs: an interview with Rob Cripe, SVP of Marketing from Tibion

The Bionic Leg is a wearable robotic trainer that is used on mobility impaired patients who need to relearn how to use their affected limb. It is used by clinicians as a tool that is designed to help strengthen stance, improve gait and enhance active motor learning.

19 Sep 2012

Obese individuals with excess visceral fat more likely to develop type 2 diabetes

Obese individuals with excess visceral fat (abdominal fat that surrounds the body-s internal organs) have an increased risk for the development of Type 2 diabetes, according to a new study by researchers at UT Southwestern Medical Center. By contrast, persons with excess abdominal subcutaneous fat (fat underneath the skin) were not at higher risk for the onset of diabetes.

19 Sep 2012

Devon Medical Products receives PDAC approval for extriCARE 2400 system

Devon Medical Products, a global medical device manufacturer and distributor, today announced it has received approval from the Pricing, Data Analysis, and Coding (PDAC) contractor for its extriCARE 2400 Negative Pressure Wound Therapy (NPWT) pump and associated bandages and disposable canister.

19 Sep 2012

FDA clears Aptus’ HeliFX Aortic Securement System

Aptus Endosystems, Inc., a medical device company developing advanced technology for endovascular aneurysm repair (EVAR), announced today that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its thoracic-length HeliFX Aortic Securement System.

From Medtronic 19 Sep 2012

AIUM grants ultrasound practice accreditation to Smith Institute for Urology

The American Institute of Ultrasound in Medicine (AIUM) recently granted ultrasound practice accreditation in urology to Smith Institute for Urology in New Hyde Park, New York. This is the first practice to receive accreditation in the practice of urology from the AIUM.

19 Sep 2012

Navidea commences enrollment in [18F]NAV4694 Phase 2 study for Alzheimer's

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that enrollment has commenced at two sites participating in its Phase 2, open-label, safety and efficacy PET imaging study of [18F]NAV4694 for detection of cerebral β-amyloid plaque in subjects diagnosed with probable Alzheimer's disease (AD).

19 Sep 2012

Xenex's pulsed xenon UV more effective than bleach in decontaminating C. diff surfaces

Healthcare associated infections (also referred to as HAIs or hospital acquired infections) are the fourth leading cause of death in the United States, costing more than $30 billion each year. Evidence continues to mount that hospital cleanliness plays a role in the spread of HAIs, which are caused by deadly pathogens such as C. diff, MRSA, VRE and Acinetobacter.

19 Sep 2012

Rainbow Biosciences explores NASA technology to produce adult stem cells for medical research

Rainbow Biosciences, the biotech subsidiary of Rainbow Coral Corp., announced today that it is exploring the possible use of micro-gravity technology developed by NASA to produce three-dimensional adult stem cells for medical research purposes.

19 Sep 2012

Illumina launches new RNA sequencing kits

Illumina today introduced TruSeq Stranded mRNA and Total RNA Sample Preparation Kits for RNA sequencing. The new reagent kits enable researchers to quickly and easily conduct gene expression studies that provide a complete view of the transcriptome, even from low-quality RNA samples, such as formalin-fixed, paraffin-embedded (FFPE) samples.

From Illumina, Inc. 19 Sep 2012

U-Systems receives FDA approval for somo-v ABUS

The U.S. Food and Drug Administration today approved the first ultrasound device for use in combination with a standard mammography in women with dense breast tissue who have a negative mammogram and no symptoms of breast cancer.

19 Sep 2012

Pediatric clearance for K2M’s treatment of adolescent idiopathic scoliosis

K2M, Inc., the largest privately held spinal device company in the world focused on developing innovative solutions for the treatment of complex spinal pathologies and minimally invasive procedures, today announced that it has received an additional clearance to treat adolescent idiopathic scoliosis.

18 Sep 2012

EmbryoScope Time-lapse system identifies abnormal development events in embryos

Which embryos have the best opportunity to develop into a viable pregnancy? A new technology provides a surprising answer. A major challenge in the field of IVF is selecting the single best embryo which is likely to result in a live birth. Currently, embryologists must remove the embryo from a standard incubator to perform 2 or 3 short evaluations of the developing embryo under the microscope, at fixed time-points over 3-5 days, in order to assess embryo quality prior to transferring an embryo to the patient.

18 Sep 2012

ChanTest announces Phase II SBIR grant to optimize cardiomyocyte-based assays

ChanTest, the leading CRO expert in ion channels and nonclinical cardiac safety testing, announces funding of a Phase II SBIR grant. ChanTest will use the grant from the National Heart Lung & Blood Institute to optimize drug safety and discovery assays using stem cell-derived human cardiomyocytes

18 Sep 2012

No link between low-level electromagnetic field exposure from mobile phones and health risks

There is no scientific evidence that low-level electromagnetic field exposure from mobile phones and other transmitting devices causes adverse health effects, according to a report presented by a Norwegian Expert Committee. In addition, the Committee provides advice to authorities about risk management and regulatory practice.

18 Sep 2012